Antiviral Cell Products against COVID-19: Learning Lessons from Previous Research in Anti-Infective Cell-Based Agents

COVID-19 is a real challenge for the protective immunity. Some people do not respond to vaccination by acquiring an appropriate immunological memory. The risk groups for this particular infection such as the elderly and people with compromised immunity (cancer patients, pregnant women, etc.) have th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chikileva, Irina, Shubina, Irina, Burtseva, Anzhelika-Mariia, Kirgizov, Kirill, Stepanyan, Nara, Varfolomeeva, Svetlana, Kiselevskiy, Mikhail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027720/
https://www.ncbi.nlm.nih.gov/pubmed/35453618
http://dx.doi.org/10.3390/biomedicines10040868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027720/
https://www.ncbi.nlm.nih.gov/pubmed/35453618
http://dx.doi.org/10.3390/biomedicines10040868

Ejemplares similares